Dimethyl Sulfoxide

Overview

Dimethylsulfoxide (DMSO) is a solvent-derived compound with anti-inflammatory and antioxidant properties, used in veterinary medicine for a variety of topical and systemic applications in dogs. Its clinical use is often based on its ability to penetrate tissues rapidly and carry small molecules across biological membranes.

DMSO is rapidly absorbed through the skin and distributes widely throughout the body following administration by any route. It is metabolized and excreted primarily via urine and feces, with additional elimination through the lungs and skin, which may produce a characteristic garlic-like or sulfur odor after administration.

Mechanism of Action (MOA): The exact mechanism of action is not fully understood. DMSO exhibits antioxidant activity, which is thought to contribute to its anti-inflammatory effects. It may also influence cellular permeability and local inflammatory responses.

Indications

DMSO is used in dogs for a variety of conditions due to its anti-inflammatory properties and ability to enhance tissue penetration. Many uses are based on clinical experience rather than strong evidence.

• Extravasation of cytotoxic drugs: Used for treatment of tissue injury caused by leakage of vesicant chemotherapeutic agents (e.g., doxorubicin).
• Calcinosis cutis: Topical application may be used to promote resolution of lesions, although evidence is largely anecdotal.
• Renal amyloidosis: Has been used as a systemic therapy, but clinical efficacy remains unproven.

Dosage (Reference)

Dog

In dogs, DMSO is used both topically and systemically depending on the condition being treated. Dosing varies widely based on indication, and careful adherence to duration and total dose limits is important to reduce adverse effects.

Cat

No specific dosing information is available for DMSO use in cats.

Warnings & Precautions

DMSO requires careful handling and cautious clinical use due to its ability to enhance transdermal absorption and its potential systemic effects following topical or parenteral administration.

• Enhanced absorption: DMSO can significantly increase the systemic absorption of substances applied concurrently to the skin; avoid combining with potentially toxic compounds.
• IV administration risk: Intravenous administration of solutions with concentrations greater than 20% may cause hemolysis and diuresis.
• Ocular effects (dogs): Chronic high-dose use has been associated with lens changes and refractive alterations; these effects are typically reversible after discontinuation.
• Local reactions: Topical application may cause irritation or erythema due to local histamine release.
• Calcinosis cutis treatment: Rapid mobilization of calcium may lead to deposition in renal tissue; monitoring of serum calcium is recommended.
• Handling precautions: Product is highly hygroscopic and should be stored in tightly closed containers; gloves should be worn during application to prevent unintended absorption.

Drug Interactions

Drug interactions with DMSO are primarily related to its ability to enhance transdermal absorption and its potential effects on concurrent therapies.

• Topical agents (general): DMSO can markedly increase systemic absorption of other substances applied to the skin; avoid co-administration with potentially toxic compounds.
• Dexrazoxane: Concurrent use may decrease the activity of dexrazoxane; combination use should be approached with caution or avoided.

Side Effects & Overdose

Side Effects

Adverse effects of DMSO in dogs are generally related to local irritation or dose-dependent systemic exposure, particularly with chronic or high-dose use.

• Local reactions: Skin irritation and erythema may occur following topical application due to histamine release.
• Ocular changes (dogs): Chronic high-dose exposure has been associated with lens opacities and changes in refractive index; these effects are slowly reversible after discontinuation.
• Systemic odor/taste effects: Excretion through lungs and skin may result in a characteristic garlic-like or sulfur odor.

Overdose

Specific overdose data in small animals are limited, but excessive dosing or high-concentration administration may result in significant systemic effects.

• High-concentration IV risk: Administration of solutions greater than 20% IV may lead to hemolysis and marked diuresis.
• Excess systemic exposure: Overuse, particularly topically, may increase systemic absorption and risk of adverse effects.
• Management: Treatment is supportive and based on clinical signs.

Key Notes

Practical clinical considerations that can help optimize the use of DMSO in dogs:

• Unique tissue penetration: DMSO has exceptional ability to penetrate skin and biological membranes, making it useful for delivering effects to deeper tissues.
• Application area matters: The extent of treated surface area directly influences systemic exposure; adjust application size based on patient size and condition severity.
• Variable clinical evidence: Many uses are based on anecdotal reports or limited studies, so expected outcomes may be inconsistent.
• Odor as a clinical indicator: The characteristic odor after administration reflects systemic distribution and can help confirm absorption.
• Route flexibility: Can be used topically, orally, or parenterally depending on indication, allowing flexible treatment approaches.
• Product selection: Only medical-grade formulations should be used; industrial formulations are not appropriate for veterinary use.
• Follow-up evaluation: Regular reassessment is important, especially in conditions with uncertain response such as calcinosis cutis or renal amyloidosis.